1. 154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors. (10th December 2020) Authors: Lutz, Eric; Rudraraju, Lakshmi; DeOliveira, Elizabeth; Seiz, Amanda; Shah, Monil; Colmenares, Celine; Fu, Beverly Dan; Bota, Daniela; Brummel, Collin; Brenner, Chad; Swiecicki, Paul; Fredrich, Nicole; Page, David; Efstatihiou, Eleni; Borrello, Ivan; Noonan, Kimberly Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; Duma, Christopher; LaRocca, Renato; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; Duma, Christopher; LaRocca, Renato; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-71. FULL ENROLLMENT RESULTS FROM THE PHASE 1/2, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) ± BEVACIZUMAB (BEV) IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, RGBM). (6th November 2017) Authors: Bota, Daniela; Desjardins, Annick; Mason, Warren; Kesari, Santosh; Magge, Rajiv; Winograd, Benjamin; Reich, Steven D; Levin, Nancy; Trikha, Mohit Journal: Neuro-oncology Issue: Volume 19(2017)Supplement 6 Page Start: vi16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS. (11th November 2019) Authors: Bota, Daniela; Taylor, Thomas; Picconi, David; Duma, Christopher; Aiken, Robert; LaRocca, Renato; Xiao-Tang, Kong; Fu, Beverly; Alsharif, Mohamad; Hsieh, Candace; Nistor, Gabriel; Dillman, Robert Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ATIM-42. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: OS CORRELATIONS WITH INITIAL AND MAXIMUM CD4+T LYMPHOCYTE COUNT IN THE PERIPHERAL BLOOD. (11th November 2019) Authors: Bota, Daniela; Taylor, Thomas; Xiao-Tang, Kong; Fu, Beverly; Alsharif, Mohamad; Pretto, Chrystel; Strik, Ankie; Schijns, Virgil; Stathopoulos, Apostolos Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. BSCI-03 THE ROLE OF LONP1 IN DRIVING ENHANCED PMT IN THE 'LEADING EDGE' NICHE IN GLIOBLASTOMA. (5th August 2022) Authors: Douglas, Christopher; Lomeli, Naomi; Bota, Daniela Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTIM-09. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: VACCINE OVERALL SURVIVAL IN BEVACIZUMAB NAIVE AND BEVACIZUMAB RESISTANT PATIENTS. (9th November 2020) Authors: Bota, Daniela; Taylor, Thomas; Kong, Xiao-Tang; Fu, Beverly; Hsu, Frank; Strik, Ankie; Schijns, Virgil; Stathopoulos, Apostolos Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTIM-26. PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; LaRocca, R; Duma, Christopher; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert T; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Hsieh, Candace; Langford, Chris; Carta, Krystal; Wang, Adrienne; Langford, James; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTIM-27. AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL. (14th November 2022) Authors: Liau, Linda M; Ashkan, Keyoumars; Brem, Steven; Campian, Jian; Trusheim, John; Iwamoto, Fabio; Tran, David; Anstass, George; Cobbs, Charles; Heth, Jason; Salacz, Michael; D'Andre, Stacy; Aiken, Robert; Moshel, Yaron; Nam, JooYeon; Pillainayagam, Clement; Wagner, Stephanie; Walter, Kevin; Chaudary... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗